Cite
TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer.
MLA
Gu, Yayun, et al. “TRAF4 Hyperactivates HER2 Signaling and Contributes to Trastuzumab Resistance in HER2-Positive Breast Cancer.” Oncogene, vol. 41, no. 35, Aug. 2022, pp. 4119–29. EBSCOhost, https://doi.org/10.1038/s41388-022-02415-6.
APA
Gu, Y., Gao, H., Zhang, H., John, A., Zhu, X., Shivaram, S., Yu, J., Weinshilboum, R. M., & Wang, L. (2022). TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer. Oncogene, 41(35), 4119–4129. https://doi.org/10.1038/s41388-022-02415-6
Chicago
Gu, Yayun, Huanyao Gao, Huan Zhang, August John, Xiujuan Zhu, Suganti Shivaram, Jia Yu, Richard M Weinshilboum, and Liewei Wang. 2022. “TRAF4 Hyperactivates HER2 Signaling and Contributes to Trastuzumab Resistance in HER2-Positive Breast Cancer.” Oncogene 41 (35): 4119–29. doi:10.1038/s41388-022-02415-6.